WO2001021011A1 - Starch product - Google Patents
Starch product Download PDFInfo
- Publication number
- WO2001021011A1 WO2001021011A1 PCT/NL2000/000653 NL0000653W WO0121011A1 WO 2001021011 A1 WO2001021011 A1 WO 2001021011A1 NL 0000653 W NL0000653 W NL 0000653W WO 0121011 A1 WO0121011 A1 WO 0121011A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- starch
- product
- treated
- process according
- debranching
- Prior art date
Links
- 229920002472 Starch Polymers 0.000 title claims abstract description 117
- 235000019698 starch Nutrition 0.000 title claims abstract description 117
- 239000008107 starch Substances 0.000 title claims abstract description 108
- 238000000034 method Methods 0.000 claims abstract description 25
- 108090000790 Enzymes Proteins 0.000 claims abstract description 24
- 102000004190 Enzymes Human genes 0.000 claims abstract description 24
- 230000008569 process Effects 0.000 claims abstract description 14
- 238000004519 manufacturing process Methods 0.000 claims abstract description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 5
- 229940088598 enzyme Drugs 0.000 claims description 23
- 229920000159 gelatin Polymers 0.000 claims description 23
- 235000019322 gelatine Nutrition 0.000 claims description 23
- 235000013305 food Nutrition 0.000 claims description 13
- 108090000637 alpha-Amylases Proteins 0.000 claims description 7
- 108010028688 Isoamylase Proteins 0.000 claims description 6
- 240000003183 Manihot esculenta Species 0.000 claims description 5
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 5
- 244000061456 Solanum tuberosum Species 0.000 claims description 5
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 240000005979 Hordeum vulgare Species 0.000 claims description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 4
- 235000007164 Oryza sativa Nutrition 0.000 claims description 4
- 235000021307 Triticum Nutrition 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 235000009566 rice Nutrition 0.000 claims description 4
- 239000002002 slurry Substances 0.000 claims description 4
- 101710117655 Maltogenic alpha-amylase Proteins 0.000 claims description 3
- 244000151018 Maranta arundinacea Species 0.000 claims description 3
- 235000010804 Maranta arundinacea Nutrition 0.000 claims description 3
- 235000012419 Thalia geniculata Nutrition 0.000 claims description 3
- 238000000518 rheometry Methods 0.000 claims description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 229940127557 pharmaceutical product Drugs 0.000 claims 2
- 239000001828 Gelatine Substances 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 239000000047 product Substances 0.000 description 40
- 108010010803 Gelatin Proteins 0.000 description 22
- 239000008273 gelatin Substances 0.000 description 22
- 235000011852 gelatine desserts Nutrition 0.000 description 22
- 238000006243 chemical reaction Methods 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 238000001914 filtration Methods 0.000 description 13
- 239000000203 mixture Substances 0.000 description 12
- 208000018756 Variant Creutzfeldt-Jakob disease Diseases 0.000 description 10
- 208000005881 bovine spongiform encephalopathy Diseases 0.000 description 10
- 239000008187 granular material Substances 0.000 description 10
- 241000283690 Bos taurus Species 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 241001494479 Pecora Species 0.000 description 7
- 102000029797 Prion Human genes 0.000 description 7
- 108091000054 Prion Proteins 0.000 description 7
- 208000024777 Prion disease Diseases 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 229920002245 Dextrose equivalent Polymers 0.000 description 6
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 6
- 239000000416 hydrocolloid Substances 0.000 description 6
- 229920001592 potato starch Polymers 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 230000008719 thickening Effects 0.000 description 6
- 239000002562 thickening agent Substances 0.000 description 6
- 229920000945 Amylopectin Polymers 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 208000008864 scrapie Diseases 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229920000856 Amylose Polymers 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 229920000881 Modified starch Polymers 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 3
- 229920002527 Glycogen Polymers 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 230000001594 aberrant effect Effects 0.000 description 3
- 102000004139 alpha-Amylases Human genes 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 229920001685 Amylomaize Polymers 0.000 description 2
- 208000020406 Creutzfeldt Jacob disease Diseases 0.000 description 2
- 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 208000003736 Gerstmann-Straussler-Scheinker Disease Diseases 0.000 description 2
- 206010072075 Gerstmann-Straussler-Scheinker syndrome Diseases 0.000 description 2
- 244000017020 Ipomoea batatas Species 0.000 description 2
- 235000002678 Ipomoea batatas Nutrition 0.000 description 2
- 240000008790 Musa x paradisiaca Species 0.000 description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 2
- 244000078534 Vaccinium myrtillus Species 0.000 description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 229940024171 alpha-amylase Drugs 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 235000011850 desserts Nutrition 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 238000003307 slaughter Methods 0.000 description 2
- UGTZMIPZNRIWHX-UHFFFAOYSA-K sodium trimetaphosphate Chemical compound [Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 UGTZMIPZNRIWHX-UHFFFAOYSA-K 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 235000012094 sugar confectionery Nutrition 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- JPSKCQCQZUGWNM-UHFFFAOYSA-N 2,7-Oxepanedione Chemical compound O=C1CCCCC(=O)O1 JPSKCQCQZUGWNM-UHFFFAOYSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 206010051290 Central nervous system lesion Diseases 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 235000019735 Meat-and-bone meal Nutrition 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 241001453300 Pseudomonas amyloderamosa Species 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 108010019077 beta-Amylase Proteins 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000009144 enzymatic modification Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 201000006061 fatal familial insomnia Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 108010061330 glucan 1,4-alpha-maltohydrolase Proteins 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 150000003944 halohydrins Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000010544 human prion disease Diseases 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000002924 oxiranes Chemical group 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000014059 processed cheese Nutrition 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01041—Pullulanase (3.2.1.41)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
- C08B30/12—Degraded, destructured or non-chemically modified starch, e.g. mechanically, enzymatically or by irradiation; Bleaching of starch
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/16—Preparation of compounds containing saccharide radicals produced by the action of an alpha-1, 6-glucosidase, e.g. amylose, debranched amylopectin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01068—Isoamylase (3.2.1.68)
Definitions
- the invention relates to a process for preparing a starch product and to the starch product obtainable by said process.
- the invention further relates to the application of the novel starch product in foodstuffs and pharmaceutical compositions.
- hydrocolloids are in general used to thicken water-based foodstuffs.
- Gelatin is a popular hydrocolloid, which, contrary to other hydrocolloids which are mainly of a polysaccharide nature, is a protein.
- Gelatin is derived from animal slaughter offal, such as skins and bones, by hydrolysis of insoluble collagen into soluble gelatin.
- Collagen is the major structural component of white tissue fibers and present in all tissues and organs of animals where it constitutes almost 30% of total protein content.
- Gelatin is used in a great number of food applications, where it is desired because it has a number of characteristics that are superior over other hydrocolloids used in the food industry. It is used for example as a thickening or gelling agent in jellied products such as confectionery and aspic type of foods; as a stabilizer and thickener in ice cream and icings, as emulsifier and thickener in dressings, desserts and sauces, as thickener in syrups and soups, as binder or thickener in general and as filling agent.
- gelatin is used in gum and jelly products, such as wine gums, as gelling agent to give the end product an elastic, gummy structure.
- gelatin is superior over other thickening (gelling and binding) agents for the clarity and elasticity it renders to the food product.
- thickening viscosity increasing
- gelling properties in one additive is very rare and not readily found among the polysaccharide based hydrocolloids.
- gelatin or hydrolyzed collagen
- gelatin hydrolyzed collagen
- Traditionally gelatin containing foodstuff has been avoided by vegetarian consumers and by consumers having a religious background that teaches to avoid gelatin. These traditional gelatin avoiding consumers were in general satisfied with buying products that contained less superior binding agents to accommodate their vegetarian and/or religious preferences. More recently, however, the general consumer, albeit not bound by vegetarian or religious preferences, is also shifting to a preference for foodstuff wherein gelatin is replaced by a different agent. This is understood as to have mainly been initiated by the recent occurrence of prion diseases such as seen with mad cow disease, and by concern that these prion diseases may infect humans when proteinaceous food of animal origin is eaten.
- BSE bovine spongiform encephalopathy
- scrapie of cattle and sheep are fatal neurodegenerative diseases caused by prion proteins and are characterized by a long incubation period.
- CJD Creutzfeldt-Jakob disease
- GSS Gerstmann-Straussler-Scheinker syndrome
- TSEs transmissible spongiform encephalopathies
- Brain homogenates from cows with BSE produce a characteristic pattern of brain lesions in mice. This is identical to the pattern elicited by brain tissue from individuals who recently have died from new-variant Creutzfeldt-Jakob disease. Up to now, this variant has caused the death of 35 young Britons and one Frenchman.
- BSE strain that seems to be transmissible to humans may have infected sheep, where it could produce a disease hardly distinguishable from scrapie.
- Sheep BSE may be a threat to human health, although scrapie by itself seems not to transmit to humans.
- BSE agent has been transmitted experimentally to sheep by the oral route and thus could have the potential to infect sheep under field conditions.
- aberrant prion protein is an abnormal form of the normal prion protein called aberrant prion protein.
- Said aberrant prion protein is mainly characterized by its resistance to proteolytic hydrolysis, it is typically quite resistant against treatment with high or low pH, and generally only looses its infectivity after prolonged treatment under high temperature.
- the invention relates to a process for preparing a starch product, wherein native starch or crosslinked starch in substantially ungelatinized state is treated with a debranching enzyme.
- the invention further relates to a starch product obtainable by said process.
- the present starch product has very advantageous properties that make it highly suitable for use as a rheology regulating agent.
- it may provide both a thickening, viscosity increasing effect, and a gelling effect, which combination is highly unusual for polysaccharides used in such applications.
- the product has a very good elasticity and its clarity can be conveniently adjusted to the envisaged application by choosing a suitable natural source for the starch used for preparing the present starch product.
- the starch product can be very conveniently processed. For instance, it allows for fast and easy separation/isolation by filtration.
- enzymatic modification can be performed in concentrated starch systems such as suspensions up to 45 % (g starch dry solids/volume) or under semi-dry conditions, above 45 % (g starch dry solids/volume).
- concentrated starch systems such as suspensions up to 45 % (g starch dry solids/volume) or under semi-dry conditions, above 45 % (g starch dry solids/volume).
- the resulting starch product can easily be separated from salts and enzymes by washing without the use of more costly and laborious methods like ion-exchange chromatography.
- the starch product can be recovered from the water phase by relatively simple methods like filtration or sedimentation, thus avoiding the use of more costly methods like e.g. spray-drying.
- enzymatically prepared starch products according to the invention retain their granular structure, thus preserving the properties of granular starches with respect to gelatmization in applications.
- Suitable starches are for example chosen from maize, wheat, barley, rice, tnticale, millet, tapioca, arrow root, banana, potato, sweet potato, high amylose type starches, such as from amylomaize, wrinkled peas, mung beans, starches with a high amylopectm content, such as waxy maize, waxy barley, waxy wheat, waxy rice, amylopectm potato, amylopectm cassave, amylopectm sweet potato or amylopectm banana.
- the starch is derived from corn, potato, wheat, rice, barley, cassava, arrowroot, sago or oat.
- starch' is intended to refer to starch that is isolated from its natural source product, but which in principle has undergone substantially no physical or chemical modification. In fact, this term is commonly used in the art to refer to such starch products.
- Crosslinked starch in general is a modified starch in which cross- links between starch macromolecules have been formed by means of bifunctional or polyfunctional chemical reagents. This results in the formation of large complexes of starch molecules of high molecular weight.
- Cross-links can be formed between amylose molecules, between amylopectin molecules, or between amylose and amylopectin molecules.
- Crosslinking starch in itself is a method known in the art for which several reagents are known. Examples of such reagents are epichlorohydrin, sodium trimetaphosphate, phosphorous oxychloride, adipic anhydride and reagents with two or more halogen, halohydrin or epoxide groups.
- the manner in which the crosslinking reaction can be carried out is, among others, described in "Modified Starches: Properties and Uses", O.B. Wurzburg, CRC
- crosslinked starch is prepared by reacting 1.2 to 12 grams of sodium trimetaphosphate or up to 2.5 grams of phosphorous oxychloride per kilogram of starch.
- starch particularly native starch
- Starch consists of discrete granules which swell up when contacted with water. This swelling is reversible. If the wet, swollen starch is dried, the original granules are recovered. If a suspension of starch granules in water is heated, the granules take up significantly more water. At a certain point, the swelling becomes irreversible and the granules are disrupted. This point is different for different starch types. Beyond this point, the viscosity increases sharply and the starch is gelatinized.
- gelatinization may also be effected in different manners, such as increasing the pH, addition of a salt or addition of an organic solvent. It is noted that the use of a debranched starch product in, for instance, foodstuffs is known per se. However, in the prior art the debranching is typically carried out using a pre gelatinized starch.
- the US patent 5,849,090 discloses a method of producing a granular resistant starch comprising debranching the starch. However, before debranching, the granular native starch is heated to gelatinize.
- isoamylase Although the use of isoamylase is also mentioned, this enzyme is only applied to a hydrolysate of starch.
- Cereal Chem. 69(4), 1992, 405-409 Jane et al. have described a process for debranching amylopectin.
- the starting material is a fractionated, solubilized starch product.
- the European patent application 0 616 778 relates to a method for opacifying a reduced-fat food, employing a partially or fully debranched starch.
- the starch is prepared by enzymatic hydrolysis of the alpha-l,6-D-glucosidic bonds of pregelatinized starch, employing an endo-alpha-l,6-D- glucanohydrolase, such as pullalanse or isoamylase.
- the European patent application 0 480 433 disclose foods containing soluble high amylose starch.
- the starch is prepared by enzymatically debranching a spray-dried, uniformly gelatinized starch.
- US patent 5,468,286 the use of enzymatically debranched starches as tablet excipients is disclosed. Before carrying out the debranching reaction, the starch is pregelatinized to permit efficient and uniform debranching.
- the factor of debranching starch in substantially ungelatinized state in accordance with the invention leads to several important advantages.
- the reaction can be carried our in a very simple and convenient fashion, for instance in a slurry with very high concentrations of solids (up to 45%) or under semi-dry conditions.
- any by-products of the reaction can be conveniently removed by washing and/or filtration.
- the drying of the product is very easy.
- the product is in granular form and is not soluble in cold water. It is very good dispersable in water, substantially without formation of agglomerates or coagulation. Dispersions of the present product are very mixable with other components in cold water, in fact they are better mixable than dispersions of pregelatinized, cold water swellable starches.
- the present process is carried out at a temperature below the gelatinization temperature of the starch used.
- this temperature lies around 60°C.
- An optimum in process conditions has been found at temperatures between 8°C, preferably 6°C, below the gelatinization temperature and the gelatinization temperature itself.
- the enzyme with which the starch is treated according to the invention is a debranching enzyme. This means that it is capable of enzymatically debranching starch. Usually, the enzymatic treatment will lead to formation of short chain amylose.
- Debranching enzymes are roughly divisible into two categories: pullulanases and isoamylases. The first category is, by the International Union of Biochemistry (1984), officially referred to as E.C. 3.2.1.41 ⁇ -dextrin endo-l,6-glucosidase.
- enzymes of this category are capable of hydrolyzing 1,6- ⁇ -D-glucosidic bonds in pullulan, glycogen and in the ⁇ - and ⁇ -limits dextrins of amylopectin and glycogen.
- the second category falls with the class of E.C. 3.2.1.68.
- Enzymes of this category are capable of hydrolyzing 1,6- ⁇ -D-glucosidic bonds in glycogen, amylopectin and their respective ⁇ -limit dextrins.
- isoamylases are well suited for debranching longer chains in the starch. Nevertheless, pullulanases have also been found to show this activity.
- Suitable pullulanases are the commercially available products known by their trade names Optimax L300 (Genencor) and Promozyme 200L (Novo Nordisk). Optimax L300 has been found to lead to particularly good results. In general, these enzymes may be added in concentrations of 0.1 to 5% (volume/weight of dry starch solids), preferably of 0.5 to 3% (volume/weight of dry starch solids).
- the pH during the enzymatic treatment is preferably chosen between 4 and 6, as the enzymes perform optimally within this range. It is further preferred that the process is carried out in a slurry or under semi-dry conditions.
- the degree of the conversion can be determined by measurement of the reducing groups that are formed as a result of debranching. This can be done e.g. by measurement of the reducing power as dextrose equivalent (DE) according to commonly used methods like Luff-Schoorl.
- DE dextrose equivalent
- Completely debranched potato starch has a DE value of around 5.0.
- Products according to the invention preferably have DE-values between 0.1 and 2.0, more preferably between 0.2 and 2.0.
- the starch product may conveniently be recovered by e.g. filtration. As the starch processed in ungelatinized condition, the starch granules will have remained intact after the reaction. Accordingly, they allow for easy filtration. Finally, the product may be dried in any suitable manner. If desired, the product may be chemically or physically modified in any known manner.
- the native starch or crosslinked starch is pre-treated with a maltogenic ⁇ -amylase before it is treated with a debranching enzyme as disclosed above. Although it has exo activity, this enzyme is officially referred to as E.C. 3.2.1.1.
- ⁇ -amylase or 1,4- ⁇ - D-glucan glucanohydrolase.
- a suitable example of a maltogenic ⁇ -amylase is can be derived from Bacillus stear other mophilus, which is produced with the aid of a genetically modified strain of Bacillus subtilis. This enzyme is commercially available from Novo Nordisk under the trade name of Maltogenase. It has been found that this pre-treatment leads to a starch product with even better gelling properties.
- This pre-treatment is preferably performed in a slurry or under semi-dry conditions at pH values between 4 and 6,preferably between 5 and 6 and a temperature between 8°C, preferably 6°C, below the gelatinization temperature of the starch.
- the invention further relates to the use of a starch product according to the invention in the preparation of a foodstuff or pharmaceutical composition, preferably partly or fully replacing gelatin in said foodstuff or pharmaceutical composition.
- a starch product according to the invention By using a product according to the invention, it is possible to replace gelatin for more than 50%, up to 80% or even 100%, depending on the requirements of the customer. It is thus now possible to reduce gelatin content and select and use minimal quantities of those gelatin batches that are absolutely prion protein free, or to fully replace animal derived thickeners, such as hydrolyzed collagen, or gelatin, that may be derived from slaughter offal comprising aberrant prion protein.
- said foodstuff is chosen from the group of baked goods, desserts, meat products, processed cheese, snacks, soups, sauces, gravies fruit fillings and confectionery, for example sugar confectionery such as hard or soft sugar confectionery, lozenges or dragees, or confectionery for diabetics wherein the sugar is replaced by artificial sweeteners.
- Such foodstuffs comprising the present starch product may be characterized by their elasticity and/or clarity.
- the invention furthermore provides a method for preparing a thickened (thickening herein also called gelling, stabilizing or binding) foodstuff comprising mixing a starch product according to the invention with a water-based liquid.
- Such a water-based liquid can for example be water, milk or another dairy product, a stock or bouillon, a sugar solution, a beverage or another water-based liquid food component known in the art.
- said method allows for the additional use of other ingredients, of which many are known in the art.
- gelatin was a first choice in thickening such liquids, however, due to consumer preference, a method to prepare non-gelatin foodstuffs is desired.
- the product obtainable by the present method may be formulated with water or plasticizer in order to manufacture shells for soft capsules, which may for instance be used as pharmaceutical dosage forms.
- Example 1 Debranching of potato starch granules.
- Food-grade potato starch containing 18 % moisture was suspended in a 2 L stirred double-walled reactor, which was equipped with a thermostated waterbath.
- the starch was suspended to a 35 % (weight dry substance / volume) concentration in demineralized water.
- the pH was adjusted to 4.4, with diluted HC1.
- the suspension was stirred at 35 r.p.m. until the content was at a temperature of 58°C.
- the reaction was initiated by the addition of 2 % (volume / g of starch dry substance) Optimax L300. After 17 hours of reaction the DE of the reaction mixture was 1.2.
- the enzyme activity was reduced by increase of the pH to 7.0 by adding diluted KOH.
- the mixture was filtered over filtration paper in a B ⁇ chner funnel and the product was washed with 10 L of demineralized water and subsequently dried at ambient temperature.
- Tapioca starch was crosslinked with 0.1 g of phosphorous oxychloride per kg. starch dry substance.
- the washed product was suspended at 35 % (weight dry substance/ volume) in a 2 L stirred double-walled reactor, which was equipped with a thermostated waterbath.
- the pH was adjusted to 4.4 with diluted HC1.
- the suspension was stirred at 35 r.p.m. until the content was at a temperature of 60 °C.
- the reaction was initiated by the addition of 0.5 % (volume / g of starch dry solids) Optimax L300. After 24 hours of reaction the DE of the reaction mixture was 1.4.
- the enzyme activity was reduced by increasing the pH to 7.0 by adding diluted KOH.
- the mixture was filtered over filtration paper in a Buchner funnel and the product was washed with 10 L of demineralized water and subsequently dried at ambient temperature.
- Food-grade potato starch containing 18 % moisture, was suspended in a 2 L stirred double-walled reactor, which was equipped with a thermostated waterbath.
- the starch was suspended to a concentration of 35 % (weight of dry subsstance / volume) in demineralized water
- the pH was adjusted to 4.4 with diluted HC1.
- the suspension was stirred at 35 r.p.m. until the desired temperature was reached (see table 1).
- the reaction was initiated by the addition 1 % (volume / g of starch dry substance) Optimax L300.
- 500 ml portions of the reaction mixtures were filtered over filtration paper in a B ⁇ chner funnel with a diameter of 17 cm.
- the filtration rate was determined by weighing the amount of fluid in the filtrate after filtration for one minute.
- the filtration rate is expressed as grams of filtrate per minute (Table 1.) Table 1. Filtration rate as function of reaction temperature.
- FIG. 1 shows the force at fracture, modulus and strain at fracture of different samples treated with Optimax L300 at different temperatures.
- Gels were prepared after gelatinisation of suspensions of the starch samples (8% dry weight) in a rapid visco-analyser. Gels 15 mm long with a diameter of 13 mm were analysed in a SMS texture analyser. The gels were compressed with a constant velocity of 0.2 mm/s by means of a spindle of 50 mm diameter until fracture occured. The force necessary for rupturing the gels is given as Force [g].
- the modulus is the derivative of strain to stress extrapolated to zero strain: d ⁇
- Example 5 Application of starches treated according to the invention in pie- filling.
- the starch described in example 2 was hydroxypropylated with 1,2- propyleneoxid to a substitution level of 0.050.
- the starch was formulated with other ingredients in bilberry pie filling as described below. Bilberry juice (30 % by weight) and water (45.4 % by weight) were mixed in a cooking pan. To this liquid was added a dry mix composed of: sugar (19 % by weight), the starch product (5.4 % by weight) and salt (0.2 % by weight). The mix was suspended with a whisk and the mixture was heated until boiling whilst stirring with a whisk. The mixture was kept boiling for 1 minute, after which the mixture was cooled to 4°C. After one day the mixture was gelled. After 7 days of storage at 4°C the mixture showed no synseresis.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Materials Engineering (AREA)
- Medicinal Chemistry (AREA)
- Jellies, Jams, And Syrups (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention relates to a process for preparing a starch product, wherein native starch or crosslinked starch in substantially ungelatinized state is treated with a debranching enzyme. The invention further relates to a starch product obtainable by said process and the use thereof in foodstuffs and pharmaceutical compositions.
Description
Title: Starch product
The invention relates to a process for preparing a starch product and to the starch product obtainable by said process. The invention further relates to the application of the novel starch product in foodstuffs and pharmaceutical compositions. In the food and pharmaceutical industries, hydrocolloids are in general used to thicken water-based foodstuffs. Gelatin is a popular hydrocolloid, which, contrary to other hydrocolloids which are mainly of a polysaccharide nature, is a protein. Gelatin is derived from animal slaughter offal, such as skins and bones, by hydrolysis of insoluble collagen into soluble gelatin. Collagen is the major structural component of white tissue fibers and present in all tissues and organs of animals where it constitutes almost 30% of total protein content.
Gelatin is used in a great number of food applications, where it is desired because it has a number of characteristics that are superior over other hydrocolloids used in the food industry. It is used for example as a thickening or gelling agent in jellied products such as confectionery and aspic type of foods; as a stabilizer and thickener in ice cream and icings, as emulsifier and thickener in dressings, desserts and sauces, as thickener in syrups and soups, as binder or thickener in general and as filling agent. For example, gelatin is used in gum and jelly products, such as wine gums, as gelling agent to give the end product an elastic, gummy structure. In particular, gelatin is superior over other thickening (gelling and binding) agents for the clarity and elasticity it renders to the food product. Moreover, the combination of both thickening (viscosity increasing) and gelling properties in one additive is very rare and not readily found among the polysaccharide based hydrocolloids.
The use of gelatin (or hydrolyzed collagen) in the food industry, however, has recently been criticized because of its animal origin. Traditionally, gelatin containing foodstuff has been avoided by vegetarian consumers and by consumers having a religious background that teaches to
avoid gelatin. These traditional gelatin avoiding consumers were in general satisfied with buying products that contained less superior binding agents to accommodate their vegetarian and/or religious preferences. More recently, however, the general consumer, albeit not bound by vegetarian or religious preferences, is also shifting to a preference for foodstuff wherein gelatin is replaced by a different agent. This is understood as to have mainly been initiated by the recent occurrence of prion diseases such as seen with mad cow disease, and by concern that these prion diseases may infect humans when proteinaceous food of animal origin is eaten. The prion diseases bovine spongiform encephalopathy (BSE) and scrapie of cattle and sheep, respectively, are fatal neurodegenerative diseases caused by prion proteins and are characterized by a long incubation period. In humans Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler-Scheinker syndrome (GSS) and fatal familial insomnia belong to this category of transmissible spongiform encephalopathies (TSEs).
Although scrapie, the prototype of the family of TSE's, in sheep and goats has been known for over 200 years and has been diagnosed world-wide, it is only since 1986 that BSE has been described in cattle in the UK. By January 1998, there had been 170,259 confirmed cases of BSE in Great Britain and there may exist a great number of cases of not yet overt cases of BSE. BSE apparently emerged because scrapie contaminated sheep offal, via meat and bone meal had been included in cattle feed, and newly infected cattle material was then recycled and eaten by susceptible cattle.
Brain homogenates from cows with BSE produce a characteristic pattern of brain lesions in mice. This is identical to the pattern elicited by brain tissue from individuals who recently have died from new-variant Creutzfeldt-Jakob disease. Up to now, this variant has caused the death of 35 young Britons and one Frenchman.
There is also concern that the BSE strain that seems to be transmissible to humans may have infected sheep, where it could produce a
disease hardly distinguishable from scrapie. Sheep BSE may be a threat to human health, although scrapie by itself seems not to transmit to humans. Indeed, BSE agent has been transmitted experimentally to sheep by the oral route and thus could have the potential to infect sheep under field conditions. Thus far, the only known cause of prion disease is an abnormal form of the normal prion protein called aberrant prion protein. Said aberrant prion protein is mainly characterized by its resistance to proteolytic hydrolysis, it is typically quite resistant against treatment with high or low pH, and generally only looses its infectivity after prolonged treatment under high temperature. Although most governments in Western society have taken strict measurements to alleviate public concerns related to mad cow disease, for example by strictly banning the use of animal products derived from animals with prion disease in the food industry, public concerns related to using the protein derived gelatin still exist, and seem to be growing. Consequently, among the general public lives a growing desire to consume non-gelatin derived foodstuff, that, however, has similar or comparable superior characteristics as the traditionally gelatin comprising foodstuffs have.
It is an object of the present invention to provide a non-protein hydrocolloid that has suitable characteristics to serve as gelatin replacement in foodstuff of varied nature or that can be used to prepare new types of foodstuff.
Surprisingly, it has now been found that a starch product which is debranched in a specific manner has the desired properties. Thus, the invention relates to a process for preparing a starch product, wherein native starch or crosslinked starch in substantially ungelatinized state is treated with a debranching enzyme. The invention further relates to a starch product obtainable by said process.
The present starch product has very advantageous properties that make it highly suitable for use as a rheology regulating agent. In particular, in water based systems it may provide both a thickening, viscosity increasing
effect, and a gelling effect, which combination is highly unusual for polysaccharides used in such applications. Furthermore, the product has a very good elasticity and its clarity can be conveniently adjusted to the envisaged application by choosing a suitable natural source for the starch used for preparing the present starch product. In addition, it has been found that the starch product can be very conveniently processed. For instance, it allows for fast and easy separation/isolation by filtration.
Further it is noted, that due to the low viscosity of ungelatinized starch, enzymatic modification can be performed in concentrated starch systems such as suspensions up to 45 % (g starch dry solids/volume) or under semi-dry conditions, above 45 % (g starch dry solids/volume). The resulting starch product can easily be separated from salts and enzymes by washing without the use of more costly and laborious methods like ion-exchange chromatography. Furthermore, the starch product can be recovered from the water phase by relatively simple methods like filtration or sedimentation, thus avoiding the use of more costly methods like e.g. spray-drying. Moreover, enzymatically prepared starch products according to the invention retain their granular structure, thus preserving the properties of granular starches with respect to gelatmization in applications. In accordance with the invention, it is preferred that a native starch or a crosslinked starch is used. Suitable starches are for example chosen from maize, wheat, barley, rice, tnticale, millet, tapioca, arrow root, banana, potato, sweet potato, high amylose type starches, such as from amylomaize, wrinkled peas, mung beans, starches with a high amylopectm content, such as waxy maize, waxy barley, waxy wheat, waxy rice, amylopectm potato, amylopectm cassave, amylopectm sweet potato or amylopectm banana. Preferably, the starch is derived from corn, potato, wheat, rice, barley, cassava, arrowroot, sago or oat.
As used m the context of the present invention, the term 'native starch' is intended to refer to starch that is isolated from its natural source
product, but which in principle has undergone substantially no physical or chemical modification. In fact, this term is commonly used in the art to refer to such starch products.
Crosslinked starch in general is a modified starch in which cross- links between starch macromolecules have been formed by means of bifunctional or polyfunctional chemical reagents. This results in the formation of large complexes of starch molecules of high molecular weight. Cross-links can be formed between amylose molecules, between amylopectin molecules, or between amylose and amylopectin molecules. Crosslinking starch in itself is a method known in the art for which several reagents are known. Examples of such reagents are epichlorohydrin, sodium trimetaphosphate, phosphorous oxychloride, adipic anhydride and reagents with two or more halogen, halohydrin or epoxide groups. The manner in which the crosslinking reaction can be carried out is, among others, described in "Modified Starches: Properties and Uses", O.B. Wurzburg, CRC
Press Inc., 1987. For food applications, it is preferred that crosslinked starch is prepared by reacting 1.2 to 12 grams of sodium trimetaphosphate or up to 2.5 grams of phosphorous oxychloride per kilogram of starch.
An important aspect of the present invention is that the native starch or crosslinked starch is treated with a debranching enzyme in substantially ungelatinized state. Starch, particularly native starch, consists of discrete granules which swell up when contacted with water. This swelling is reversible. If the wet, swollen starch is dried, the original granules are recovered. If a suspension of starch granules in water is heated, the granules take up significantly more water. At a certain point, the swelling becomes irreversible and the granules are disrupted. This point is different for different starch types. Beyond this point, the viscosity increases sharply and the starch is gelatinized. Instead of raising the temperature, gelatinization may also be effected in different manners, such as increasing the pH, addition of a salt or addition of an organic solvent.
It is noted that the use of a debranched starch product in, for instance, foodstuffs is known per se. However, in the prior art the debranching is typically carried out using a pre gelatinized starch.
The US patent 5,849,090, for instance, discloses a method of producing a granular resistant starch comprising debranching the starch. However, before debranching, the granular native starch is heated to gelatinize.
In the European patent application 0 806 434, a high solids enzyme conversion process for preparing a liquified enzyme-converted starch is described. In a first step, a single phase powdered mixture without a visible free water phase is prepared. When the powdered mixture starch contains a granular starch, as the powdered mixture is heated, the heat and moisture initiate the swelling of the starch granules and the starch is completely or partially gelatinized and simultaneously converted. US patent 3,922,196 deals with enzymatic hydrolysis of granular starch. Enzymes that are employed for the solubilization of starch are α- amylase, glucoamylase, maltogenic amylase or β-amylase. Although the use of isoamylase is also mentioned, this enzyme is only applied to a hydrolysate of starch. In Cereal Chem. 69(4), 1992, 405-409, Jane et al. have described a process for debranching amylopectin. However, the starting material is a fractionated, solubilized starch product.
Kimura et al., Carbohydrate Research 287 (1996) 255-261, have made a comparison between a reaction of an isoamylase of Pseudomonas amyloderamosa with native and gelatinized starch granules. The reactions are all carried out at 37°C. The percentage reaction of all starches under these conditions is below 12%, for potato starch it is as low as 3.7%. The percentage reaction in this regard is defined as the ratio between the sum of the reducing capabilities of the dissolved and rest granule fractions and the reducing capability of the dissolved starch, after the reaction. In accordance with the
present invention it is preferred that the temperature during the debranching reaction is much higher. The percentage reaction that is achieved is between 20 and 40%.
The European patent application 0 616 778 relates to a method for opacifying a reduced-fat food, employing a partially or fully debranched starch. The starch is prepared by enzymatic hydrolysis of the alpha-l,6-D-glucosidic bonds of pregelatinized starch, employing an endo-alpha-l,6-D- glucanohydrolase, such as pullalanse or isoamylase.
Similarly, the European patent application 0 480 433 disclose foods containing soluble high amylose starch. The starch is prepared by enzymatically debranching a spray-dried, uniformly gelatinized starch. In US patent 5,468,286, the use of enzymatically debranched starches as tablet excipients is disclosed. Before carrying out the debranching reaction, the starch is pregelatinized to permit efficient and uniform debranching.
The factor of debranching starch in substantially ungelatinized state in accordance with the invention leads to several important advantages. The reaction can be carried our in a very simple and convenient fashion, for instance in a slurry with very high concentrations of solids (up to 45%) or under semi-dry conditions. In addition, any by-products of the reaction can be conveniently removed by washing and/or filtration. Furthermore, the drying of the product is very easy. The product is in granular form and is not soluble in cold water. It is very good dispersable in water, substantially without formation of agglomerates or coagulation. Dispersions of the present product are very mixable with other components in cold water, in fact they are better mixable than dispersions of pregelatinized, cold water swellable starches.
In a preferred embodiment, the present process is carried out at a temperature below the gelatinization temperature of the starch used. For starch derived from potatoes, this temperature lies around 60°C. An optimum in process conditions has been found at temperatures between 8°C, preferably
6°C, below the gelatinization temperature and the gelatinization temperature itself.
The enzyme with which the starch is treated according to the invention is a debranching enzyme. This means that it is capable of enzymatically debranching starch. Mostly, the enzymatic treatment will lead to formation of short chain amylose. Debranching enzymes are roughly divisible into two categories: pullulanases and isoamylases. The first category is, by the International Union of Biochemistry (1984), officially referred to as E.C. 3.2.1.41 α-dextrin endo-l,6-glucosidase. By definition, enzymes of this category are capable of hydrolyzing 1,6-α-D-glucosidic bonds in pullulan, glycogen and in the α- and β-limits dextrins of amylopectin and glycogen. The second category falls with the class of E.C. 3.2.1.68. Enzymes of this category are capable of hydrolyzing 1,6-α-D-glucosidic bonds in glycogen, amylopectin and their respective β-limit dextrins. In general, isoamylases are well suited for debranching longer chains in the starch. Nevertheless, pullulanases have also been found to show this activity. Examples of suitable pullulanases are the commercially available products known by their trade names Optimax L300 (Genencor) and Promozyme 200L (Novo Nordisk). Optimax L300 has been found to lead to particularly good results. In general, these enzymes may be added in concentrations of 0.1 to 5% (volume/weight of dry starch solids), preferably of 0.5 to 3% (volume/weight of dry starch solids).
The pH during the enzymatic treatment is preferably chosen between 4 and 6, as the enzymes perform optimally within this range. It is further preferred that the process is carried out in a slurry or under semi-dry conditions.
The degree of the conversion can be determined by measurement of the reducing groups that are formed as a result of debranching. This can be done e.g. by measurement of the reducing power as dextrose equivalent (DE) according to commonly used methods like Luff-Schoorl. Completely debranched potato starch has a DE value of around 5.0. Products according to
the invention preferably have DE-values between 0.1 and 2.0, more preferably between 0.2 and 2.0.
Once the enzymatic reaction has reached its desired extent of completion, the starch product may conveniently be recovered by e.g. filtration. As the starch processed in ungelatinized condition, the starch granules will have remained intact after the reaction. Accordingly, they allow for easy filtration. Finally, the product may be dried in any suitable manner. If desired, the product may be chemically or physically modified in any known manner. In a preferred embodiment of the invention, the native starch or crosslinked starch is pre-treated with a maltogenic α-amylase before it is treated with a debranching enzyme as disclosed above. Although it has exo activity, this enzyme is officially referred to as E.C. 3.2.1.1. α-amylase or 1,4-α- D-glucan glucanohydrolase. A suitable example of a maltogenic α-amylase is can be derived from Bacillus stear other mophilus, which is produced with the aid of a genetically modified strain of Bacillus subtilis. This enzyme is commercially available from Novo Nordisk under the trade name of Maltogenase. It has been found that this pre-treatment leads to a starch product with even better gelling properties.
This pre-treatment is preferably performed in a slurry or under semi-dry conditions at pH values between 4 and 6,preferably between 5 and 6 and a temperature between 8°C, preferably 6°C, below the gelatinization temperature of the starch.
The invention further relates to the use of a starch product according to the invention in the preparation of a foodstuff or pharmaceutical composition, preferably partly or fully replacing gelatin in said foodstuff or pharmaceutical composition. By using a product according to the invention, it is possible to replace gelatin for more than 50%, up to 80% or even 100%, depending on the requirements of the customer. It is thus now possible to reduce gelatin content and select and use minimal quantities of those gelatin batches that are absolutely prion protein free, or to fully replace animal
derived thickeners, such as hydrolyzed collagen, or gelatin, that may be derived from slaughter offal comprising aberrant prion protein. In a preferred embodiment, said foodstuff is chosen from the group of baked goods, desserts, meat products, processed cheese, snacks, soups, sauces, gravies fruit fillings and confectionery, for example sugar confectionery such as hard or soft sugar confectionery, lozenges or dragees, or confectionery for diabetics wherein the sugar is replaced by artificial sweeteners. Such foodstuffs comprising the present starch product may be characterized by their elasticity and/or clarity. The invention furthermore provides a method for preparing a thickened (thickening herein also called gelling, stabilizing or binding) foodstuff comprising mixing a starch product according to the invention with a water-based liquid. Such a water-based liquid can for example be water, milk or another dairy product, a stock or bouillon, a sugar solution, a beverage or another water-based liquid food component known in the art. Of course, said method allows for the additional use of other ingredients, of which many are known in the art. Traditionally, gelatin was a first choice in thickening such liquids, however, due to consumer preference, a method to prepare non-gelatin foodstuffs is desired.
It is further envisaged that the product obtainable by the present method may be formulated with water or plasticizer in order to manufacture shells for soft capsules, which may for instance be used as pharmaceutical dosage forms.
The invention will now be elucidated by the following, non- restrictive examples.
Example 1. Debranching of potato starch granules.
Food-grade potato starch, containing 18 % moisture was suspended in a 2 L stirred double-walled reactor, which was equipped with a thermostated
waterbath. The starch was suspended to a 35 % (weight dry substance / volume) concentration in demineralized water. The pH was adjusted to 4.4, with diluted HC1. The suspension was stirred at 35 r.p.m. until the content was at a temperature of 58°C. The reaction was initiated by the addition of 2 % (volume / g of starch dry substance) Optimax L300. After 17 hours of reaction the DE of the reaction mixture was 1.2. The enzyme activity was reduced by increase of the pH to 7.0 by adding diluted KOH. The mixture was filtered over filtration paper in a Bύchner funnel and the product was washed with 10 L of demineralized water and subsequently dried at ambient temperature.
Example 2. Debranching of crosslinked tapioca starch.
Tapioca starch was crosslinked with 0.1 g of phosphorous oxychloride per kg. starch dry substance. The washed product was suspended at 35 % (weight dry substance/ volume) in a 2 L stirred double-walled reactor, which was equipped with a thermostated waterbath. The pH was adjusted to 4.4 with diluted HC1. The suspension was stirred at 35 r.p.m. until the content was at a temperature of 60 °C. The reaction was initiated by the addition of 0.5 % (volume / g of starch dry solids) Optimax L300. After 24 hours of reaction the DE of the reaction mixture was 1.4. The enzyme activity was reduced by increasing the pH to 7.0 by adding diluted KOH. The mixture was filtered over filtration paper in a Buchner funnel and the product was washed with 10 L of demineralized water and subsequently dried at ambient temperature.
Example 3. Filtration properties of debranched starch.
Food-grade potato starch, containing 18 % moisture, was suspended in a 2 L stirred double-walled reactor, which was equipped with a thermostated waterbath. The starch was suspended to a concentration of 35 % (weight of dry subsstance / volume) in demineralized water The pH was adjusted to 4.4 with diluted HC1. The suspension was stirred at 35 r.p.m. until the desired temperature was reached (see table 1). The reaction was initiated by the addition 1 % (volume / g of starch dry substance) Optimax L300. After reaction for 19 hours at the temperature indicated in Table 1, 500 ml portions of the reaction mixtures were filtered over filtration paper in a Bύchner funnel with a diameter of 17 cm. The filtration rate was determined by weighing the amount of fluid in the filtrate after filtration for one minute. The filtration rate is expressed as grams of filtrate per minute (Table 1.) Table 1. Filtration rate as function of reaction temperature.
Example 4. Rheology of starches debranched according to the invention.
Potato starches were debranched as described under Example 1, at the temperatures given in Figure 1. Figure 1 shows the force at fracture, modulus and strain at fracture of different samples treated with Optimax L300 at different temperatures. Gels were prepared after gelatinisation of suspensions of the starch samples (8% dry weight) in a rapid visco-analyser. Gels 15 mm long with a diameter of 13 mm were analysed in a SMS texture analyser. The
gels were compressed with a constant velocity of 0.2 mm/s by means of a spindle of 50 mm diameter until fracture occured. The force necessary for rupturing the gels is given as Force [g]. The modulus is the derivative of strain to stress extrapolated to zero strain: dσ
whereas the (Hencky) strain at fracture is defined as
Example 5. Application of starches treated according to the invention in pie- filling.
The starch described in example 2 was hydroxypropylated with 1,2- propyleneoxid to a substitution level of 0.050. The starch was formulated with other ingredients in bilberry pie filling as described below. Bilberry juice (30 % by weight) and water (45.4 % by weight) were mixed in a cooking pan. To this liquid was added a dry mix composed of: sugar (19 % by weight), the starch product (5.4 % by weight) and salt (0.2 % by weight). The mix was suspended with a whisk and the mixture was heated until boiling whilst stirring with a whisk. The mixture was kept boiling for 1 minute, after which the mixture was cooled to 4°C. After one day the mixture was gelled. After 7 days of storage at 4°C the mixture showed no synseresis.
Claims
1. A process for preparing a starch product, wherein starch in substantially ungelatinized state is treated with a debranching enzyme.
2. A process according to claim 1, wherein the starch is treated with the debranching enzyme at a temperature below the gelatinization temperature.
3. A process according to claim 1 or 2, wherein the debranching enzyme is a pullulanase, or isoamylase.
4. A process according to any of the preceding claims, wherein the starch is derived from corn, potato, wheat, rice, barley, cassava, arrowroot, sago or oat.
5. A process according to any of the preceding claims, wherein the starch is treated with the debranching enzyme at a pH of 4-6.
6. A process according to any of the preceding claims, wherein the starch is treated with the debranching enzyme in a slurry or under semi-dry conditions.
7. A process according to any of the preceding claims, wherein the native starch or crosslinked starch is pre-treated with a maltogenic α-amylase.
8. A starch product obtainable by a process according to any of the preceding claims.
9. Use of a starch product according to claim 8 in a food or pharmaceutical product.
10. Use according to claim 9, wherein the starch product at least partly replaces gelatine in said food or pharmaceutical product.
11. Use of a starch product according to claim 8 as a rheology regulating agent.
12. Foodstuff or pharmaceutical composition comprising a starch product according to claim 8.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU75616/00A AU7561600A (en) | 1999-09-17 | 2000-09-14 | Starch product |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99203058.5 | 1999-09-17 | ||
EP99203058 | 1999-09-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001021011A1 true WO2001021011A1 (en) | 2001-03-29 |
Family
ID=8240653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NL2000/000653 WO2001021011A1 (en) | 1999-09-17 | 2000-09-14 | Starch product |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU7561600A (en) |
WO (1) | WO2001021011A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1362919A1 (en) * | 2002-05-14 | 2003-11-19 | National Starch and Chemical Investment Holding Corporation | Slowly digestible starch product |
EP1366674A1 (en) * | 2002-05-28 | 2003-12-03 | Coöperatieve Verkoop- en Productievereniging van Aardappelmeel en Derivaten 'AVEBE' B.A. | Food additive |
WO2004064540A1 (en) * | 2003-01-17 | 2004-08-05 | Cerestar Holding B.V. | Aqueous gels prepared from pea starch derivatives |
US7687248B2 (en) | 2003-09-08 | 2010-03-30 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Resistant starch with cooking properties similar to untreated starch |
US11350643B2 (en) | 2016-11-28 | 2022-06-07 | Corn Products Development, Inc. | Starch-based texturizers for low protein yogurt |
US11382334B2 (en) | 2016-11-28 | 2022-07-12 | Corn Products Development, Inc. | Starch-based texturizers for low protein yogurt, yogurt composiiton and method of making the yogurt composition |
US11571013B2 (en) | 2016-11-28 | 2023-02-07 | Corn Products Development, Inc. | Starch-based texturizers for food compositions |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3922196A (en) * | 1974-01-28 | 1975-11-25 | Cpc International Inc | Enzymatic hydrolysis of granular starch |
EP0480433A2 (en) * | 1990-10-12 | 1992-04-15 | National Starch and Chemical Investment Holding Corporation | Foods containing soluble high amylose starch |
EP0616778A1 (en) * | 1988-10-14 | 1994-09-28 | National Starch and Chemical Investment Holding Corporation | Foods opacified with debranched starch |
US5468286A (en) * | 1989-10-25 | 1995-11-21 | National Starch And Chemical Investment Holding Corporation | Enzymatically debranched starches as tablet excipients |
EP0806434A1 (en) * | 1996-05-06 | 1997-11-12 | National Starch and Chemical Investment Holding Corporation | High solids, single phase process for preparing enzyme converted starches |
US5849090A (en) * | 1996-03-27 | 1998-12-15 | Opta Food Ingredients, Inc. | Granular resistant starch and method of making |
-
2000
- 2000-09-14 AU AU75616/00A patent/AU7561600A/en not_active Abandoned
- 2000-09-14 WO PCT/NL2000/000653 patent/WO2001021011A1/en active Search and Examination
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3922196A (en) * | 1974-01-28 | 1975-11-25 | Cpc International Inc | Enzymatic hydrolysis of granular starch |
EP0616778A1 (en) * | 1988-10-14 | 1994-09-28 | National Starch and Chemical Investment Holding Corporation | Foods opacified with debranched starch |
US5468286A (en) * | 1989-10-25 | 1995-11-21 | National Starch And Chemical Investment Holding Corporation | Enzymatically debranched starches as tablet excipients |
EP0480433A2 (en) * | 1990-10-12 | 1992-04-15 | National Starch and Chemical Investment Holding Corporation | Foods containing soluble high amylose starch |
US5849090A (en) * | 1996-03-27 | 1998-12-15 | Opta Food Ingredients, Inc. | Granular resistant starch and method of making |
EP0806434A1 (en) * | 1996-05-06 | 1997-11-12 | National Starch and Chemical Investment Holding Corporation | High solids, single phase process for preparing enzyme converted starches |
Non-Patent Citations (2)
Title |
---|
A.KIMURA, J.F. ROBYT: "Reaction of Enzymes with Starch Granules: Reaction of Isoamylase with Native and Gelatinized Starch", CARBOHYDRATE RESEARCH., vol. 287, 1996, ELSEVIER SCIENTIFIC PUBLISHING COMPANY. AMSTERDAM., NL, pages 255 - 261, XP002129687, ISSN: 0008-6215 * |
J.JANE: "Location of Amylose in Normal Starch Granules. I. Susceptibility of Amylose and Amylopectin to Cross-Linking Reagents", CEREAL CHEMISTRY., vol. 69, no. 4, 1992, AMERICAN ASSOCIATION OF CEREAL CHEMISTS. MINNEAPOLIS., US, pages 405 - 409, XP002129688 * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100401912C (en) * | 2002-05-14 | 2008-07-16 | 国家淀粉及化学投资控股公司 | Slowly digestible starch products |
EP1362919A1 (en) * | 2002-05-14 | 2003-11-19 | National Starch and Chemical Investment Holding Corporation | Slowly digestible starch product |
US6929817B2 (en) | 2002-05-14 | 2005-08-16 | National Starch & Chemical Investment Holding Corporation | Slowly digestible starch product |
AU2003204158B2 (en) * | 2002-05-14 | 2007-08-30 | Brunob Ii B.V. | Slowly digestable starch product |
EP1366674A1 (en) * | 2002-05-28 | 2003-12-03 | Coöperatieve Verkoop- en Productievereniging van Aardappelmeel en Derivaten 'AVEBE' B.A. | Food additive |
WO2003099038A1 (en) * | 2002-05-28 | 2003-12-04 | Coöperatieve Verkoop- En Productievereniging Van Aardappelmeel En Derivaten Avebe B.A. | Food additive |
US7344741B2 (en) | 2002-05-28 | 2008-03-18 | Cooperatie Avebe U.A. | Food additive |
WO2004064540A1 (en) * | 2003-01-17 | 2004-08-05 | Cerestar Holding B.V. | Aqueous gels prepared from pea starch derivatives |
US7687248B2 (en) | 2003-09-08 | 2010-03-30 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Resistant starch with cooking properties similar to untreated starch |
US7700327B2 (en) * | 2003-09-08 | 2010-04-20 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Resistant starch with cooking properties similar to untreated starch |
US11350643B2 (en) | 2016-11-28 | 2022-06-07 | Corn Products Development, Inc. | Starch-based texturizers for low protein yogurt |
US11382334B2 (en) | 2016-11-28 | 2022-07-12 | Corn Products Development, Inc. | Starch-based texturizers for low protein yogurt, yogurt composiiton and method of making the yogurt composition |
US11571013B2 (en) | 2016-11-28 | 2023-02-07 | Corn Products Development, Inc. | Starch-based texturizers for food compositions |
Also Published As
Publication number | Publication date |
---|---|
AU7561600A (en) | 2001-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003204158B2 (en) | Slowly digestable starch product | |
AU2003204155B2 (en) | Slowly digestable starch product | |
AU2003204157B2 (en) | Resistant starch prepared by isoamylase debranching of low amylose starch | |
EP1146795B2 (en) | Composition based on cross-linked starch and depolymerised starch suitable as gelatine replacement | |
US5436019A (en) | Method of preparing reduced fat foods | |
US6890579B2 (en) | Reversible gel formation | |
TW200804428A (en) | Production of crystalline short chain amylose | |
US5904941A (en) | Use of enzymatically-treated starches as viscosifiers and their use in food products | |
JPH1042804A (en) | Starch treated under high pressure | |
EP0529892A1 (en) | Fragmented, alpha amylase hydrolysed amylose precipitate as fat replacer | |
WO2001021011A1 (en) | Starch product | |
JPH08176202A (en) | Production of hydrolyzed starch | |
JP3066568B2 (en) | Low viscosity solution | |
WO1993010675A1 (en) | Fragmented alpha amylase hydrolyzed amylose precipitate as fat replacer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: JP |